Childrens Hospital LA, CalTech Hire ICAP Ocean Tomo to Sell Non-Invasive Detection Tech

ICAP Ocean Tomo has conducted due diligence to rate the strength of the patents and is marketing the portfolio to various healthcare and other companies that might be interested in commercializing the technology, which can be used to monitor a patient's blood glucose or substances in the brain and cerebrospinal fluid.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.